CIBC Private Wealth Group’s Avanos Medical AVNS Stock Holding History

CIBC Private Wealth Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$13.5K	Buy	1,200 +415	+53%	+$4.75K	﹤0.01%	2313
2025 Q3	$9.07K	Hold	785	–	–	﹤0.01%	2419
2025 Q2	$9.61K	Hold	785	–	–	﹤0.01%	2274
2025 Q1	$9.73K	Sell	785 -6,447	-89%	-$101K	﹤0.01%	2254
2024 Q4	$111K	Sell	7,232 -20	-0.3%	-$396	﹤0.01%	1381
2024 Q3	$174K	Buy	7,252 +1,840	+34%	+$42.1K	﹤0.01%	1253
2024 Q2	$106K	Buy	5,412 +288	+6%	+$5.61K	﹤0.01%	1377
2024 Q1	$100K	Buy	+5,124	New	+$99K	﹤0.01%	1399
2018 Q3	–	Sell	-895	Closed	-$51K	–	1025
2018 Q2	$51K	Sell	895 -33	-4%	-$1.74K	﹤0.01%	1160
2018 Q1	$43K	Hold	928	–	–	﹤0.01%	1192
2017 Q4	$43K	Buy	+928	New	+$42.7K	﹤0.01%	1219

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group's AVNS Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Avanos Medical (AVNS) stake by 53% in Q4 2025, buying an estimated $4.75K and bringing the position to 1,200 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

CIBC Private Wealth Group first reported a position in AVNS in Q4 2017 and has held it in 11 quarters since. The position peaked at $174K in Q3 2024. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

CIBC Private Wealth Group held 1,200 shares of Avanos Medical worth $13.5K as of Q4 2025.
CIBC Private Wealth Group bought 415 Avanos Medical shares in Q4 2025, an estimated $4.75K.
Avanos Medical made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2313 holding.
CIBC Private Wealth Group first reported a position in Avanos Medical in Q4 2017 and has held it in 11 quarters since.
CIBC Private Wealth Group's Avanos Medical position peaked at $174K in Q3 2024.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.